U.S. Electric Utilities Stock News

U.S. Gold Corp. (NasdaqCM:USAU) released its Feasibility Study results for the fully permitted CK Gold Project in Wyoming. The study outlines project economics and highlights options such as mine expansion, longer mine life and additional revenue sources. The CK Gold Project is described as shovel ready, with all key permits in place. U.S. Gold, trading at $15.8, sits at a notable point in its development, with the CK Gold Project having cleared a major technical and regulatory hurdle. The...

Investors may be wondering whether Community Trust Bancorp at around US$61.58 still offers value, or if most of the upside is already reflected in the price. The stock has returned 2.4% over the last week, 0.1% over the past month, 9.2% year to date and 26.6% over the last year, with longer term returns of 86.2% over 3 years and 70.3% over 5 years. Recent coverage has focused on Community Trust Bancorp's position in the regional banking space and how investors are assessing its fundamentals...

Occidental Petroleum recently enjoyed a multi-day run of gains that lifted its market value to about US$65.00 billion amid improving analyst sentiment. Behind the rally, a strong wave of upward earnings estimate revisions and a top-tier Zacks Rank #1 suggests analysts see meaningfully better profit prospects than before. Next, we’ll examine how this sharp upgrade in earnings expectations and sentiment could influence Occidental Petroleum’s existing investment narrative. Explore 25 top...

If you are wondering whether Legend Biotech's share price reflects its underlying value, this article breaks down what the current market price may be implying about the company. The stock closed at US$19.05, with returns of 8.2% over the last week and 3.3% over the last month. The 1 year return stands at a 42.7% decline and the 3 year return at a 60.5% decline. Recent coverage around Legend Biotech has focused on its position in the biotech space and how investors are reassessing risk and...

KORE Group Holdings (KORE) reported Q3 FY 2025 revenue of US$68.7 million with a basic EPS loss of US$0.64, alongside trailing twelve month revenue of US$285.4 million and a TTM EPS loss of US$3.57, underscoring that the business is still operating in loss-making territory. Over recent quarters the company has seen revenue hold in a fairly tight band around the US$68 million to US$73 million range, while quarterly EPS losses have moved between roughly US$0.64 and US$1.31. The focus for...

Taylor Devices (TAYD) just turned in its Q3 2026 scorecard, with recent quarterly figures showing revenue between about US$8.5 million and US$15.6 million over the past six reported quarters and EPS ranging from US$0.34 to US$1.17. Across that stretch, revenue moved from US$8.55 million in Q2 2025 to US$11.60 million in Q2 2026, while EPS shifted from US$0.34 to US$0.64, setting up a results season in which investors are paying close attention to how firmly margins are holding. See our full...

XCF Global (SAFX) closed FY 2025 with Q4 revenue of US$4.7 million and a basic EPS loss of US$0.09, alongside trailing twelve month EPS of US$0.52 on revenue of US$20.8 million that reflects the move into profitability over the past year. Over recent quarters the company has seen revenue shift from US$0 in Q1 2025 to US$6.6 million in Q2, US$9.6 million in Q3, then US$4.7 million in Q4. Quarterly EPS moved from a loss of US$0.05 in Q1 to a gain of US$0.83 in Q2 before returning to losses in...

Crypto and blockchain stocks sit at the intersection of technology, finance, and changing market plumbing, which can be appealing when geopolitical tensions, energy prices, and bond yields keep shifting. With manufacturing data mixed across regions and input costs under pressure, many investors are looking beyond traditional sectors to themes tied to digital infrastructure and alternative transaction systems. Our Top Cryptocurrency and Blockchain Stocks screener filters this broad universe...

JFB Construction Holdings (JFB) has just posted another tough set of numbers for FY 2025, with Q3 revenue of US$5.0 million and a basic EPS loss of US$0.05, set against a trailing 12 month revenue decline of 20.4% and no net profit over the period. The company has seen quarterly revenue move from US$7.1 million in Q4 2024 to US$5.9 million in Q1 2025, US$3.7 million in Q2 2025, and US$5.0 million in Q3 2025. EPS shifted from a modest profit of US$0.02 per share in Q4 2024 to small gains in Q1...

Maui Land & Pineapple Company (MLP) opened FY 2025 with mixed quarterly numbers, reporting Q3 revenue of US$4.5 million and basic EPS of US$0.01, set against a trailing 12 month net loss of US$11.3 million on revenue of US$18.3 million. Over recent quarters, revenue has ranged from US$2.6 million to US$5.8 million per quarter, while basic EPS has moved between a loss of US$0.44 and a small profit of US$0.01 as reported for Q3 2025. For investors, the latest figures keep the spotlight on...

Phoenix Asia Holdings (PHOE) has just posted its H1 2026 scorecard, with trailing 12 month revenue of about US$7.4 million and net income of roughly US$1.0 million, translating to EPS of US$0.06, while the latest half year print for H2 2025 showed revenue of US$3.6 million and EPS of US$0.02. Over the last reported halves, the company has seen total revenue move from US$2.8 million in H2 2024 to US$3.8 million in H1 2025 and US$3.6 million in H2 2025, with EPS of roughly US$0.04 in both H2...

SEALSQ (LAES) just posted its FY 2025 first half numbers with revenue of roughly US$4.8 million and a basic EPS loss of US$0.17, against a trailing twelve month loss of US$0.38 per share on about US$11.0 million of revenue. Over the last three reported half year periods, revenue has moved between about US$4.8 million and US$6.2 million, while basic EPS losses ranged from US$0.17 to US$0.60. This has kept margins firmly in the red and put the focus squarely on how the business can turn growing...

Patriot National Bancorp (PNBK) just closed out FY 2025 with fourth quarter revenue of US$9.8 million and a basic EPS loss of US$0.02, alongside trailing twelve month revenue of US$28.1 million and a basic EPS loss of US$0.17. Over recent quarters the company has seen revenue move from US$4.7 million in Q2 2025 to US$7.6 million in Q3 2025 and then to US$9.8 million in Q4 2025. Quarterly basic EPS losses narrowed from US$0.21 in Q1 2025 to US$0.06 in Q2, US$0.03 in Q3 and US$0.02 in Q4...

AleAnna (NasdaqCM:ANNA) has just posted another quarter of rapid top line expansion, with Q3 FY 2025 revenue of about US$11.2 million and basic EPS of US$0.08, against a backdrop of very large revenue growth of 2,471.5% over the past year while remaining unprofitable on a trailing 12 month view. Over recent periods the company has seen revenue move from roughly US$0.6 million in Q3 FY 2024 to US$11.2 million in Q3 FY 2025, while trailing 12 month EPS across the last reported quarters stayed...

KULR Technology Group (KULR) closed FY 2025 with fourth quarter revenue of US$2.9 million and a basic EPS loss of US$0.97, alongside a trailing twelve month EPS loss of US$1.56 on revenue of US$16.2 million. Over the last few quarters, the company has reported revenue between US$2.4 million and US$6.9 million per quarter, while quarterly EPS has ranged from a loss of US$0.54 to a gain of US$0.22. This leaves investors focusing on how quickly these top line changes might translate into...

FitLife Brands (FTLF) has just closed out FY 2025 with fourth quarter revenue of US$25.9 million and basic EPS of US$0.17, alongside trailing twelve month revenue of US$81.5 million and EPS of US$0.68 that investors will be watching against the prior year’s figures. Over recent quarters the company has seen revenue move from US$15.0 million in Q4 FY 2024 to US$25.9 million in Q4 FY 2025, while quarterly EPS shifted from US$0.23 to US$0.17, setting the backdrop for the latest full year read on...

Dawson Geophysical (DWSN) closed out FY 2025 with fourth quarter revenue of US$26.9 million and basic EPS of US$0.02, alongside net income of US$0.6 million. This set a cleaner finish to a year where the trailing twelve month figures still show a loss of US$1.9 million on US$75.6 million of revenue and a basic EPS loss of US$0.06. Over recent quarters the company has seen quarterly revenue range from US$9.9 million to US$26.9 million, with EPS moving between a loss of US$0.08 and a profit of...

Alkermes (NasdaqGS:ALKS) has begun Phase 3 clinical trials for alixorexton, its orexin 2 receptor agonist for narcolepsy type 1 and type 2. The late stage Brilliance Studies aim to evaluate alixorexton in patients with significant unmet treatment needs in sleep disorders. This marks a new development in Alkermes' pipeline beyond prior focus areas highlighted in earlier coverage. For Alkermes, known for its work in neuroscience and psychiatry, the Brilliance Studies add a new dimension to...

Jiayin Group Inc. has reported its fourth-quarter and full-year 2025 results, showing quarterly revenue of CNY 1,090.2 million and net income of CNY 100.63 million, alongside full-year revenue of CNY 6,222.19 million and net income of CNY 1,535.74 million. Alongside these results, the company increased its dividend payout framework to target around 30% of prior-year net income and completed a share repurchase of 4,600,000 shares, equal to 8.6% of its share count, signaling a stronger focus...

Core & Main (NYSE:CNM) has appointed former American Water Works CEO M. Susan Hardwick to its board, effective April 1. The company has restructured key governance roles, including a new board chair and a new audit committee chair. The longstanding executive chair has retired as part of the succession changes. Core & Main, trading at $49.4, is adjusting its leadership structure after a 3-year return of 121.8% and a 1-year return of 0.0%. The share price has seen a 2.3% decline over the past...

Ocugen (NasdaqCM:OCGN) completed enrollment and dosing early in its pivotal Phase 2/3 GARDian3 trial for OCU410ST. The trial evaluates a one time gene therapy candidate for Stargardt disease, a severe inherited retinal disorder with no approved treatments. This is Ocugen's second late stage clinical program and aligns with its stated goal to submit multiple BLAs by 2028. For readers tracking gene therapy names, Ocugen sits at the intersection of rare ophthalmology and inherited retinal...

Vera Therapeutics has appointed Jane Wright-Mitchell as its new Chief Legal Officer. Wright-Mitchell brings extensive legal, compliance, and intellectual property experience in life sciences and pharmaceuticals. The appointment adds senior leadership depth as Vera Therapeutics continues to develop its pipeline. The new Chief Legal Officer steps in at a time when Vera Therapeutics, listed as NasdaqGM:VERA, is trading at $40.23. The share price reflects a mixed return profile, with a 1.2%...

FirstSun Capital Bancorp (NasdaqGS:FSUN) has been removed from the Russell 2000 Defensive Index. The company has also been dropped from the Russell 2500 Defensive, Russell 2500 Value-Defensive, and Russell 2000 Value-Defensive indices. This index reclassification affects how some passive and rules based funds may hold or view the stock. FirstSun Capital Bancorp, the holding company for FirstBank, operates as a regional banking platform focused on commercial and consumer financial services...

In the last week, the United States market has stayed flat but is up 16% over the past year, with earnings forecasted to grow by 15% annually. In this context, identifying high growth tech stocks involves looking for companies that demonstrate strong potential for sustained revenue and earnings expansion in alignment with these broader market trends.